Thiamet-G ameliorates Parkinson's disease-associated cognitive impairment via increasing O-GlcNAcylation of STING in the microglia
Neurochemistry International · 2025-09 · 188 · 106014
DOI: 10.1016/j.neuint.2025.106014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2025-09. Verfasst von Shanshan Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Microglia, Cognitive Dysfunction, Thiazoles, Membrane Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Program of Hunan Province, University of Sadat City, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Microglia activation contributed to the development of Parkinson's disease (PD)-associated cognitive impairment and targeting microglia may be a promising strategy for improving the cognitive function in PD. O-GlcNAclytion is a novel protein post-translational modification with cognitive enhancing effects. This study aimed to investigate the effects of Thiamet-G (TMG), an O-GlcNAcase inhibitor that can increase the intracellular O-GlcNAclytion levels, on PD-associated cognitive impairment and the mechanism related to microglia activation. A PD mouse model was established using rotenone (ROT) and the cognitive functions of these mice were investigated by behavioral tests. The anti-inflammatory effects of TMG were tested in the BV2 microglia cells. TMG treatment significantly improved the cognitive function in the ROT-induced PD mouse model as evidenced by the Y-maze test and objective recognition test. Histological studies showed that TMG decreased the reactive microglia via increasing the total protein O-GlcNAclytion levels in the hippocampus of the PD mice. In the in vitro studies, TMG inhibited ROT-induced inflammation via decreasing the pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6 in BV2 microglia cells. Bioinformatic analysis revealed that STING, a core protein in the innate immunity regulation, might be a novel target of O-GlcNAclytion. The immunoprecipitation experiments further confirmed that TMG inhibited STING phosphorylation via increasing O-GlcNAcylation. Taken together, TMG might ameliorate PD-associated cognitive impairment via increasing O-GlcNAcylation of STING in microglia, which provided evidence supporting that inhibiting the inflammatory response of microglia by elevating the O-GlcNAclytion levels might be an effective strategy for improving the cognitive function in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Hengyang Medical School, University of South China, Hengyang, China.
- Department of Histology and Embryology, Hengyang Medical School, University of South China, Hengyang, China; Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang…
Förderung
- Science and Technology Program of Hunan Province
- University of Sadat City
- Natural Science Foundation of Jiangxi Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhu, S., Wang, N., Chen, S., Zou, J., & Tan, S. (2025). Thiamet-G ameliorates Parkinson's disease-associated cognitive impairment via increasing O-GlcNAcylation of STING in the microglia. Neurochemistry International, 188, 106014. https://doi.org/10.1016/j.neuint.2025.106014
Vancouver
Zhu S, Wang N, Chen S, Zou J, Tan S. Thiamet-G ameliorates Parkinson's disease-associated cognitive impairment via increasing O-GlcNAcylation of STING in the microglia. Neurochemistry International. 2025;188:106014. doi:10.1016/j.neuint.2025.106014
BibTeX
@article{Zhu2025,
author = {Zhu, Shanshan and Wang, Nan and Chen, Shuyang and Zou, Ju and Tan, Sijie},
title = {Thiamet-G ameliorates Parkinson's disease-associated cognitive impairment via increasing O-GlcNAcylation of STING in the microglia},
journal = {Neurochemistry International},
year = {2025},
volume = {188},
pages = {106014},
doi = {10.1016/j.neuint.2025.106014}
}
EUVIMED